Digest Network Come funziona
Network
/
Società
Ar
Non verificato

Ariceum Therapeutics

Di cosa scriviamo

BiologiaBiotecnologiaEconomiaFarmaceuticaSanità

11 comunicati stampa

Guarda tutti i comunicati
10/11/2025
Biotecnologia
Medicina Salute Benessere
Ariceum Therapeutics Doses First Patient in SANTANA-225 Phase 1/2 Clinical Trial of 225Ac-SSO110 in Patients with Extensive-Stage Small Cell Lung Cancer or Merkel Cell Carcinoma
Fonte
Ariceum Therapeutics
Emittente
GLOBENEWSWIRE
1.00
0
08/10/2025
Biotecnologia
Annunci Economici
Ariceum Therapeutics Data at the 2025 European Association of Nuclear Medicine Annual Congress Further Supports the Advancement of 225Ac-SSO110 for Extensive Stage Small Cell Lung Cancer and Merkel Cell Carcinoma
Fonte
Ariceum Therapeutics
Emittente
GLOBENEWSWIRE
1.00
0
25/08/2025
Biotecnologia
Medicina Salute Benessere
Ariceum Therapeutics Appoints David Schilansky as Chief Executive Officer and Announces New Leadership to Advance Next Phase of Development
Fonte
Ariceum Therapeutics
Emittente
GLOBENEWSWIRE
1.00
0
06/02/2025
Farmaceutica
Sanità
Biologia
U.S. FDA Grants Orphan Drug Designation to Ariceum Therapeutics' Proprietary Radiopharmaceutical Cancer Therapy
Fonte
Ariceum Therapeutics
Emittente
PR News Wire
1.00
0
14/01/2025
Farmaceutica
Sanità
Biologia
FDA Clears Ariceum Therapeutics' 225Ac-Satoreotide Phase I/II Clinical Study in Patients with Small Cell Lung Cancer or Merkel Cell Carcinoma
Fonte
Ariceum Therapeutics
Emittente
PR News Wire
1.00
0
10/01/2025
Farmaceutica
Sanità
Economia
Management
Organizzazione Aziendale
Biologia
David Schilansky Appointed Chief Financial Officer of Ariceum Therapeutics
Fonte
Ariceum Therapeutics
Emittente
PR News Wire
1.00
0
11/12/2024
Farmaceutica
Sanità
Imprese
Organizzazione Aziendale
Biologia
Ariceum Therapeutics and NorthStar Medical Radioisotopes Announce Supply Agreement for Therapeutic Radioisotope Actinium-225
Fonte
Ariceum Therapeutics
Emittente
PR News Wire
1.00
0
05/12/2024
Farmaceutica
Sanità
Biologia
Ariceum Therapeutics and Eckert & Ziegler Sign Global Supply Agreement for the Development of Next-Generation Radiotherapeutics for Precision Cancer Treatments
Fonte
Ariceum Therapeutics
Emittente
PR News Wire
1.00
0
22/10/2024
Farmaceutica
Sanità
Scienza
Biologia
Ariceum Therapeutics Presents Outstanding Data on its First-in-Class Radiopharmaceutical Drug 225Ac-Satoreotide at the European Association of Nuclear Medicine 2024
Fonte
Ariceum Therapeutics
Emittente
PR News Wire
1.00
0
25/07/2024
Farmaceutica
Sanità
Economia
Start-up
Biologia
Ariceum Therapeutics Commences Phase 1 Clinical Trial in Patients with Recurrent Glioblastoma
Fonte
Ariceum Therapeutics
Emittente
PR News Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0